GlassScriptPhysician profile
Michael J Flintrop
NPI 1376581702
$6,244.11
in general payments reported to CMS, 2019-2025
32 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,155 · 2020: $511 · 2021: $758 · 2022: $529 · 2023: $735 · 2024: $456 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194 · Education: $97.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.69 |
| Education | $97.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,634.82 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,127.76 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Grifols USA, LLC | $601.24 | 2019-2025 | Prolastin-C Liquid |
| Pulmonx Corporation | $383.45 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Genzyme Corporation | $299.93 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.37 | 2019-2025 | Ofev |
| Insmed, INC. | $177.76 | 2019-2024 | Arikayce |
| Genentech USA, INC. | $171.15 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $165.05 | 2020-2024 | Acthar |
| United Therapeutics Corporation | $159.65 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $145.90 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $141.49 | 2019 | |
| Baxter Healthcare | $127.43 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Pfizer INC. | $125.50 | 2019-2025 | |
| Inspire Medical Systems, INC. | $117.37 | 2025 | Inspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $96.16 | 2019-2024 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $77.15 | 2020-2024 | Glassia |
| Electromed, INC. | $57.58 | 2023-2024 | Smartvest |
| Gilead Sciences, INC. | $40.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.54 | 2019-2020 | |
| Circassia INC. | $31.83 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.80 | 2019-2021 | |
| Mylan Specialty L.P. | $30.56 | 2019-2021 | |
| Shire North American Group INC | $28.73 | 2019 | |
| Inogen, INC. | $27.01 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $26.83 | 2019-2020 | |
| Philips North America LLC | $25.34 | 2019 | |
| Axsome Therapeutics, INC. | $19.23 | 2024 | Sunosi |
| Harmony Biosciences LLC | $18.66 | 2023 | Wakix |
| Jazz Pharmaceuticals INC. | $17.73 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.40 | 2020 | |
| Veran Medical Technologies, INC. | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flintrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.